Defect of CARD9 leads to impaired accumulation of gamma interferon-producing memory phenotype T cells in lungs and increased susceptibility to pulmonary infection with cryptococcus neoformans

Infection and Immunity

Volumn 82, Issue 4, 2014, Pages 1606-1615

  Yamamoto, Hideki ^a   Nakamura, Yuri ^a   Sato, Ko ^a   Takahashi, Yurie ^a   Nomura, Toshiki ^a   Miyasaka, Tomomitsu ^a,e   Ishii, Keiko ^a   Hara, Hiromitsu ^b   Yamamoto, Natsuo ^c   Kanno, Emi ^a   Iwakura, Yoichiro ^d   Kawakami, Kazuyoshi ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b SAGA UNIVERSITY   (Japan)

^c FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

^d TOKYO UNIVERSITY OF SCIENCE   (Japan)

^e TOHOKU PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE RECRUITMENT DOMAIN CONTAINING PROTEIN 9; CXCL9 CHEMOKINE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; PROTEIN; RANTES; RNA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CRYPTOCOCCUS NEOFORMANS; CYTOKINE PRODUCTION; FEMALE; FUNGAL CLEARANCE; GENE DISRUPTION; INFECTION SENSITIVITY; INNATE IMMUNITY; MALE; MEMORY T LYMPHOCYTE; MOUSE; NONHUMAN; PATHOGEN CLEARANCE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DEFECT; PULMONARY CRYPTOCOCCOSIS; TH17 CELL; WILD TYPE;

ANIMALS; CARD SIGNALING ADAPTOR PROTEINS; CHEMOKINES; CRYPTOCOCCUS NEOFORMANS; DISEASE MODELS, ANIMAL; IMMUNITY, INNATE; INTERFERON-GAMMA; LUNG DISEASES, FUNGAL; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; T-LYMPHOCYTES; TH1 CELLS; TH17 CELLS;

EID: 84896440873     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.01089-13     Document Type: Article

References (51)

1. Cunha BA. 2001. Central nervous system infections in the compromised host: a diagnostic approach. Infect. Dis. Clin. North Am. 15:567-590. http://dx.doi.org/10.1016/S0891-5520(05)70160-4.
2. Jarvis JN, Harrison TS. 2007. HIV-associated cryptococcal meningitis. AIDS 21:2119-2129. http://dx.doi.org/10.1097/QAD.0b013e3282a4a64d.
3. Lim TS, Murphy JW. 1980. Transfer of immunity to cryptococcosis by T-enriched splenic lymphocytes from Cryptococcus neoformans-sensitized mice. Infect. Immun. 30:5-11.
4. Perfect JR, Casadevall A. 2002. Cryptococcosis. Infect. Dis. Clin. North Am. 16:837-874. http://dx.doi.org/10.1016/S0891-5520(02)00036-3.
5. Koguchi Y, Kawakami K. 2002. Cryptococcal infection and Th1-Th2 cytokine balance. Int. Rev. Immunol. 21:423-438. http://dx.doi.org/10.1080/08830180213274.
6. Yuan RR, Casadevall A, Oh J, Scharff MD. 1997. T cells cooperate with passive antibody to modify Cryptococcus neoformans infection in mice. Proc. Natl. Acad. Sci. U. S. A. 94:2483-2488. http://dx.doi.org/10.1073/pnas.94.6.2483.
7. Kawakami K, Koguchi Y, Qureshi MH, Miyazato A, Yara S, Kinjo Y, Iwakura Y, Takeda K, Akira S, Kurimoto M, Saito A. 2000. IL-18 contributes to host resistance against infection with Cryptococcus neoformans in mice with defective IL-12 synthesis through induction of IFN-γ production by NK cells. J. Immunol. 165:941-947.
8. Decken K, Köhler G, Palmer-Lehmann K, Wunderlin A, Mattner F, Magram J, Gately MK, Alber G. 1998. Interleukin-12 is essential for a protective Th1 response in mice infected with Cryptococcus neoformans. Infect. Immun. 66:4994-5000.
9. Rayhane N, Lortholary O, Fitting C, Callebert J, Huerre M, Dromer F, Cavaillon JM. 1999. Enhanced sensitivity of tumor necrosis factor/lymphotoxin-α-deficient mice to Cryptococcus neoformans infection despite increased levels of nitrite/nitrate, interferon-γ, and interleukin-12. J. Infect. Dis. 180:1637-1647. http://dx.doi.org/10.1086/315061.
10. Blackstock R, Buchanan KL, Adesina AM, Murphy JW. 1999. Differential regulation of immune responses by highly and weakly virulent Cryptococcus neoformans isolates. Infect. Immun. 67:3601-3609.
11. Blackstock R, Murphy JW. 2004. Role of interleukin-4 in resistance to Cryptococcus neoformans infection. Am. J. Respir. Cell Mol. Biol. 30:109-117. http://dx.doi.org/10.1165/rcmb.2003-0156OC.
12. Müller U, Stenzel W, Köhler G, Werner C, Polte T, Hansen G, Schutzen N, Straubinger RK, Blessing M, Ackenzie AN, Brombacher F, Alber G. 2007. IL-13 induces disease-promoting type 2 cytokines, alternatively activated macrophages and allergic inflammation during pulmonary infection of mice with Cryptococcus neoformans. J. Immunol. 179:5367-5377. http://www.jimmunol.org/content/179/8/5367.long.
13. Huang W, Na L, Fidel PL, Schwarzenberger P. 2004. Requirement of interleukin-17A for systemic anti-Candida albicans host defense in mice. J. Infect. Dis. 190:624-631. http://dx.doi.org/10.1086/422329.
14. Conti HR, Gaffen SL. 2010. Host responses to Candida albicans: Th17 cells and mucosal candidiasis. Microbes Infect. 12:518-527. http://dx.doi.org/10.1016/j.micinf.2010.03.013.
15. Korn T, Bettelli E, Oukka M, Kuchroo VK. 2009. IL-17 and Th17 cells. Annu. Rev. Immunol. 27:485-517. http://dx.doi.org/10.1146/annurev.immunol.021908.132710.
16. Lipscomb MF, Alvarellos T, Toews GB, Tompkins R, Evans Z, Koo G, Kumar V. 1987. Role of natural killer cells in resistance to Cryptococcus neoformans infections in mice. Am. J. Pathol. 128:354-361.
17. Kawakami K, Kinjo Y, Uezu K, Yara S, Miyagi K, Koguchi Y, Nakayama T, Taniguchi M, Saito A. 2001. Monocyte chemoattractant protein-1-dependent increase of Vα14 NKT cells in lungs and their roles in Th1 response and host defense in cryptococcal infection. J. Immunol. 167: 6525-6532. http://www.jimmunol.org/content/167/11/6525.long.
18. Uezu K, Kawakami K, Miyagi K, Kinjo Y, Kinjo T, Ishikawa H, Saito A. 2004. Accumulation of γδ T cells in the lungs and their regulatory roles in Th1 response and host defense against pulmonary infection with Cryptococcus neoformans. J. Immunol. 172:7629-7634. http://www.jimmunol.org/content/172/12/7629.long.
19. Figdor G, van Kooyk Y, Adema GJ. 2002. C-type lectin receptors on dendritic cells and Langerhans cells. Nat. Rev. Immunol. 2:77-84. http://dx.doi.org/10.1038/nri723.
20. LeibundGut-Landmann S, Gross O, Robinson MJ, Osorio F, Slack EC, Tsoni SV, Schweighoffer E, Tybulewicz V, Brown GD, Ruland J, Reis e Sousa C. 2007. Syk-and CARD9-dependent coupling of innate immunity to the induction of T helper cells that produce interleukin 17. Nat. Immunol. 8:630-638. http://dx.doi.org/10.1038/ni1460.
21. Taylor PR, Tsoni SV, Willment JA, Dennehy KM, Rosas M, Findon H, Haynes K, Steele C, Botto M, Gordon S, Brown GD. 2007. Dectin-1 is required for beta-glucan recognition and control of fungal infection. Nat. Immunol. 8:31-38. http://dx.doi.org/10.1038/ni1408.
22. Saijo S, Fujikado N, Furuta T, Chung SH, Kotaki H, Seki K, Sudo K, Akira S, Adachi Y, Ohno N, Kinjo T, Nakamura K, Kawakami K, Iwakura Y. 2007. Dectin-1 is required for the host defense against Pneumocystis carinii but not against Candida albicans. Nat. Immunol. 8:39-46. http://dx.doi.org/10.1038/ni1425.
23. Saijo S, Ikeda S, Yamabe K, Kakuta S, Ishigame H, Akitsu A, Fujikado N, Kusaka T, Kubo S, Chung SH, Komatsu H, Miura N, Adachi Y, Ohno N, Shibuya K, Yamamoto N, Kawakami K, Yamasaki S, Saito T, Akira S, Iwakura Y. 2010. Dectin-2 recognition of alpha-mannans and induction of Th17 cell differentiation is essential for the host defense against Candida albicans. Immunity 32:681-691. http://dx.doi.org/10.1016/j.immuni.2010.05.001.
24. Mansour MK, Schlesinger LS, Levitz SM. 2002. Optimal T cell responses to Cryptococcus neoformans mannoprotein are dependent on recognition of conjugated carbohydrates by mannose receptors. J. Immunol. 168: 2872-2879. http://www.jimmunol.org/content/168/6/2872.long.
25. Mansour MK, Latz E, Levitz SM. 2006. Cryptococcus neoformans glycoantigens are captured by multiple lectin receptors and presented by dendritic cells. J. Immunol. 176:3053-3061. http://www.jimmunol.org/content/17 6/5/3053.long.
26. Nakamura K, Kinjo T, Saijo S, Miyazato A, Adachi Y, Ohno N, Fujita J, Kaku M, Iwakura Y, Kawakami K. 2007. Dectin-1 is not required for the host defense to Cryptococcus neoformans. Microbiol. Immunol. 51: 1115-1119. http://dx.doi.org/10.1111/j.1348-0421.2007.tb04007.x.
27. Hara H, Ishihara C, Takeuchi A, Imanishi T, Xue L, Morris SW, Inui M, Takai T, Shibuya A, Saijo S, Iwakura Y, Ohno N, Koseki H, Yoshida H, Penninger JM, Saito T. 2007. The adaptor protein CARD9 is essential for the activation of myeloid cells through ITAM-associated and Toll-like receptors. Nat. Immunol. 8:619-629. http://dx.doi.org/10.1038/ni1466.
28. Gross O, Gewies A, Finger F, Schafer M, Sparwasser T, Peschel C, Forster I, Ruland J. 2006. Card9 controls a non-TLR signaling pathway for innate anti-fungal immunity. Nature 442:651-656. http://dx.doi.org/10.1038/nature04926.
29. Dorhoi A, Desel C, Yeremeev V, Pradl L, Brinkmann V, Mollenkopf HJ, Hanke K, Gross O, Ruland J, Kaufmann SH. 2010. The adaptor molecule CARD9 is essential for tuberculosis control. J. Exp. Med. 207:777-792. http://dx.doi.org/10.1084/jem.20090067.
30. Hsu YM, Zhang Y, You Y, Wang D, Li H, Duramad O, Qin XF, Dong C, Lin X. 2007. The adaptor protein CARD9 is required for innate immune responses to intracellular pathogens. Nat. Immunol. 8:198-205. http://dx.doi.org/10.1038/ni1426.
31. Nakae S, Komiyama Y, Nambu A, Sudo K, Iwase M, Homma I, Sekikawa K, Asano M, Iwakura Y. 2002. Antigen-specific T cell sensitization is impaired in IL-17-deficient mice, causing suppression of allergic cellular and humoral responses. Immunity 17:375-387. http://dx.doi.org/10.1016/S1074-7613(02)00391-6.
32. Kawakami K, Kohno S, Morikawa N, Kadota J, Saito A, Hara K. 1994. Activation of macrophages and expansion of specific T lymphocyte in the lungs of mice intratracheally inoculated with Cryptococcus neoformans. Clin. Exp. Immunol. 96:230-237.
33. + T cells following a microbe exposure. J. Immunol. 168:1198-1203.
34. + T cell response to respiratory virus infections. Immunity 29:101-113. http://dx.doi.org/10.1016/j.immuni.2008.05.011.
35. Sung JH, Zhang H, Moseman EA, Alvarez D, Iannacone M, Henrickson SE, de la Torre JC, Goom JR, Luster AD, von Andrian UH. 2012. Chemokine guidance of central memory T cells is critical for antiviral recall responses in lymph nodes. Cell 150:1249-1263. http://dx.doi.org/10.1016/j.cell.2012.08.015.
36. Grégoire C, Cognet C, Chasson L, Coupet CA, Dalod M, Reboldi A, Marvel J, Sallusto F, Vivier E, Walzer T. 2008. Intrasplenic trafficking of natural killer cells is redirected by chemokines upon inflammation. Eur. J. Immunol. 38:2076-2084. http://dx.doi.org/10.1002/eji.200838550.
37. Pak-Wittel MA, Yang L, Sojka DK, Rivenbark JG, Yokoyama WM. 2013. Interferon-γ mediates chemokine-dependent recruitment of natural killer cells during viral infection. Proc. Natl. Acad. Sci. U. S. A. 110: E50-E59. http://dx.doi.org/10.1073/pnas.1220456110.
38. Robertson MJ. 2002. Role of chemokines in the biology of natural killer cells. J. Leukoc. Biol. 71:173-183. http://www.jleukbio.org/content/71/2/173.long.
39. Drummond RA, Saijo S, Iwakura Y, Brown GD. 2011. The role of Syk/CARD9 coupled C-type lectins in antifungal immunity. Eur. J. Immunol. 41:276-281. http://dx.doi.org/10.1002/eji.201041252.
40. Wu W, Hsu YM, Bi L, Songyang Z, Lin X. 2009. CARD9 facilitates microbe-elicited production of reactive oxygen species by regulating the LyGDI-Rac1 complex. Nat. Immunol. 10:1208-1214. http://dx.doi.org/10.1038/ni.1788.
41. Feldmesser M, Tucker S, Casadevall A. 2001. Intracellular parasitism of macrophages by Cryptococcus neoformans. Trends Microbiol. 9:273-278. http://dx.doi.org/10.1016/S0966-842X(01)02035-2.
42. Tohyama M, Kawakami K, Futenma M, Saito A. 1996. Enhancing effect of oxygen radical scavengers on murine macrophage anticryptococcal activity through production of nitric oxide. Clin. Exp. Immunol. 103:436-441.
43. + T cells in IL-15 transgenic mice are involved in early protection against a primary infection with Listeria monocytogenes. Eur. J. Immunol. 31:757-766. http://dx.doi.org/10.1002/1521-4141(200103)31:3<757::AID-IMMU757>3.0.CO;2-Q.
44. + CTL after reinfection. J. Immunol. 174:3590-3597. http://www.jimmunol.org/content/174/6/3590.long.
45. Rossi D, Zlotnik A. 2000. The biology of chemokines and their receptors. Annu. Rev. Immunol. 18:217-242. http://dx.doi.org/10.1146/annurev.immunol.18.1.217.
46. Hardison SE, Wozniak KL, Kolls JK, Wormley FL, Jr. 2010. Interleukin-17 is not required for classical macrophage activation in a pulmonary mouse model of Cryptococcus neoformans infection. Infect. Immun. 78: 5341-5351. http://dx.doi.org/10.1128/IAI.00845-10.
47. Wozniak KL, Hardison SE, Kolls JK, Wormley FL. 2011. Role of IL-17A on resolution of pulmonary C. neoformans infection. PLoS One 6:e17204. http://dx.doi.org/10.1371/journal.pone.0017204.
48. Gu C, Wu L, Li X. 2013. IL-17 family: cytokines, receptors and signaling. Cytokines 64:477-485. http://dx.doi.org/10.1016/j.cyto.2013.07.022.
49. Sabat R, Ouyang W, Wolk K. 2013. Therapeutic opportunities of the IL-22-IL-22R1 system. Nat. Rev. Drug Discov. 13:21-38. http://dx.doi.org/10.1038/nrd4176.
50. Yauch LE, Mansour MK, Shoham S, Rottman JB, Levitz SM. 2004. Involvement of CD14, toll-like receptors 2 and 4, and MyD88 in the host response to the fungal pathogen Cryptococcus neoformans in vivo. Infect. Immun. 72:5373-5382. http://dx.doi.org/10.1128/IAI.72.9.5373-5382.2004.
51. Zhang Y, Wang F, Bhan U, Huffnagle GB, Toews GB, Standiford TJ, Olszewski MA. 2010. TLR9 signaling is required for generation of the adaptive immune protection in Cryptococcus neoformans-infected lungs. Am. J. Pathol. 177:754-765. http://dx.doi.org/10.2353/ajpath.2010.091104.